The Department of Health and Human Services Guidance allows pharmacists to order and administer FDA-approved COVID-19 tests, superseding any state-level barriers to doing so.
NACDS' new report urges national and state leaders to ensure that pharmacists and pharmacies are fully utilized to provide essential services and support to the national effort to combat the COVID-19 pandemic.
Gilead has inked deals with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan to manufacture remdesivir for distribution in 127 countries.